– Sulzer at a glance – Our key figures
Our key figures
Order intake by division
2021
Order intake by region
2021
Key figures
|
millions of CHF |
|
2021 |
|
2020 1) |
|
Change in +/–% |
|
+/–% adjusted 2) |
|
+/–% organic 3) |
|
Order intake from continuing operations |
|
3’167.6 |
|
3’049.2 |
|
3.9 |
|
3.6 |
|
0.9 |
|
Order intake gross margin from continuing operations |
|
33.1% |
|
32.6% |
|
|
|
|
|
|
|
Order backlog from continuing operations as of December 31 |
|
1’724.1 |
|
1’676.8 |
|
2.8 |
|
|
|
|
|
Sales from continuing operations |
|
3’155.3 |
|
2’967.8 |
|
6.3 |
|
6.0 |
|
3.5 |
|
EBIT from continuing operations |
|
221.8 |
|
132.5 |
|
67.4 |
|
|
|
|
|
Operational profit from continuing operations |
|
293.3 |
|
255.0 |
|
15.1 |
|
14.1 |
|
10.9 |
|
Operational profitability from continuing operations |
|
9.3% |
|
8.6% |
|
|
|
|
|
|
|
Operational ROCEA from continuing operations |
|
22.7% |
|
21.3% |
|
|
|
|
|
|
|
Core net income from continuing operations |
|
195.3 |
|
165.6 |
|
17.9 |
|
|
|
|
|
Net income from continuing operations |
|
140.7 |
|
71.5 |
|
96.7 |
|
|
|
|
|
Basic earnings per share from continuing operations (in CHF) |
|
4.10 |
|
2.00 |
|
104.9 |
|
|
|
|
|
Free cash flow (FCF) |
|
238.7 |
|
272.1 |
|
–12.3 |
|
|
|
|
|
Net debt as of December 31 |
|
66.8 |
|
414.5 |
|
–83.9 |
|
|
|
|
|
Employees (number of full-time equivalents) from continuing operations as of December 31 |
|
13’816 |
|
13’197 |
|
4.7 |
|
|
|
|
1) Comparative information has been re-presented due to discontinued operations (details are described in note 7 to the consolidated financial statements).
2) Adjusted for currency effects.
3) Adjusted for acquisition and currency effects.
Stock market information
|
|
|
2021 |
|
2020 |
|
2019 |
|
2018 |
|
2017 |
|
Registered share (in CHF) |
|
|
|
|
|
|
|
|
|
|
|
– high |
|
144.40 |
|
110.50 |
|
113.40 |
|
137.50 |
|
129.90 |
|
– low 1) |
|
92.35 |
|
40.12 |
|
75.15 |
|
76.30 |
|
102.30 |
|
– year-end 1) |
|
134.85 |
|
93.10 |
|
108.00 |
|
78.05 |
|
118.20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Market capitalization as of December 31 1) |
|
|
|
|
|
|
|
|
|
|
|
– number of shares outstanding |
|
33’727’637 |
|
33’835’903 |
|
34’021’446 |
|
33’950’499 |
|
34’043’093 |
|
– in millions of CHF |
|
4’548 |
|
3’150 |
|
3’674 |
|
2’650 |
|
4’024 |
|
– in percentage of equity |
|
357% |
|
224% |
|
232% |
|
163% |
|
240% |
|
|
|
|
|
|
|
|
|
|
|
|
|
P/E ratio as of December 31 |
|
3.2x |
|
37.8x |
|
23.9x |
|
21.9x |
|
48.4x |
|
Dividend yield as of December 31 |
|
2.6% |
|
4.3% |
|
3.7% |
|
4.5% |
|
3.0% |
1) Including CHF 45.00 per share from medmix spin-off.
Data per share
|
CHF |
|
2021 |
|
2020 |
|
2019 |
|
2018 |
|
2017 |
|
Net income attributable to a shareholder of Sulzer Ltd |
|
41.93 |
|
2.46 |
|
4.52 |
|
3.56 |
|
2.44 |
|
Change from prior year |
|
1’603% |
|
–46% |
|
27% |
|
46% |
|
41% |
|
Equity attributable to a shareholder of Sulzer Ltd |
|
37.80 |
|
41.50 |
|
46.50 |
|
48.00 |
|
49.40 |
|
Ordinary dividend |
|
3.50 1) |
|
4.00 |
|
4.00 |
|
3.50 |
|
3.50 |
|
Payout ratio |
|
8% |
|
163% |
|
88% |
|
98% |
|
143% |
|
Average number of shares outstanding |
|
33’788’006 |
|
33’970’141 |
|
34’026’442 |
|
31’934’459 |
|
34’084’133 |
1) Proposal to the Annual General Meeting.
Shareholder structure as of December 31, 2021
|
Number of shares |
|
Number of shareholders |
|
Shareholding |
|
1–100 |
|
4’170 |
|
0.7% |
|
101–1’000 |
|
4’783 |
|
4.6% |
|
1’001–10’000 |
|
580 |
|
4.6% |
|
10’001–100’000 |
|
95 |
|
8.2% |
|
More than 100’000 |
|
11 |
|
58.7% |
|
Total registered shareholders and shares (excluding treasury shares Sulzer Ltd) |
|
9’639 |
|
76.7% |